Volume 24, Issue 6, Pages (June 2006)

Slides:



Advertisements
Similar presentations
Volume 7, Issue 5, Pages (November 1997)
Advertisements

Volume 36, Issue 3, Pages (March 2012)
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 26, Issue 3, Pages (March 2007)
LPS-Induced Upregulation of SHIP Is Essential for Endotoxin Tolerance
Volume 9, Issue 5, Pages (November 1998)
Transforming Growth Factor-β Signaling Curbs Thymic Negative Selection Promoting Regulatory T Cell Development  Weiming Ouyang, Omar Beckett, Qian Ma,
The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCθ and ERK pathways by Gilles Despouy, Marjorie Joiner, Emilie Le Toriellec,
Volume 43, Issue 4, Pages (October 2015)
CD74 induces TAp63 expression leading to B-cell survival
Volume 10, Issue 4, Pages (October 2006)
Volume 26, Issue 3, Pages (March 2007)
Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition by Jinsong Hu, Nana Dang, Eline Menu, Elke De Bryune, Dehui Xu, Ben Van.
by Alexander Kiani, Francisco J
Volume 31, Issue 2, Pages (August 2009)
Effects of Betulinic Acid Alone and in Combination with Irradiation in Human Melanoma Cells  Edgar Selzer, Emilio Pimentel, Volker Wacheck, Werner Schlegel,
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
by Mi-Ae Kang, Su-Young Yun, and Jonghwa Won
Volume 120, Issue 2, Pages (January 2005)
Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets by Maria Nikolova, Jean-Daniel Lelievre, Matthieu.
AKT Delays the Early-Activated Apoptotic Pathway in UVB-Irradiated Keratinocytes Via BAD Translocation  Sofie Claerhout, David Decraene, An Van Laethem,
Volume 15, Issue 1, Pages (January 2007)
The BH3-mimetic GX synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak by Patricia Pérez-Galán, Gaël.
Volume 120, Issue 6, Pages (March 2005)
Volume 30, Issue 4, Pages (April 2009)
Volume 26, Issue 1, Pages (January 2007)
Volume 29, Issue 6, Pages (December 2008)
Volume 32, Issue 6, Pages (June 2010)
Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML)‏ by Michaela Scherr, Anuhar Chaturvedi, Karin.
Volume 31, Issue 1, Pages (July 2009)
Impaired Proteasome Function Activates GATA3 in T Cells and Upregulates CTLA-4: Relevance for Sézary Syndrome  Heather M. Gibson, Anjali Mishra, Derek.
Acquisition of a Functional T Cell Receptor during T Lymphocyte Development Is Enforced by HEB and E2A Transcription Factors  Mary Elizabeth Jones, Yuan.
Volume 41, Issue 2, Pages (January 2011)
Volume 39, Issue 1, Pages (July 2013)
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
Volume 34, Issue 5, Pages (May 2011)
A Two-Step Process for Thymic Regulatory T Cell Development
Volume 24, Issue 2, Pages (February 2006)
Novel Role of the Ras Cascade in Memory B Cell Response
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
Volume 43, Issue 6, Pages (December 2015)
Oncogenic Ras-Induced Expression of Noxa and Beclin-1 Promotes Autophagic Cell Death and Limits Clonogenic Survival  Mohamed Elgendy, Clare Sheridan,
Volume 32, Issue 6, Pages (June 2010)
Volume 22, Issue 2, Pages (February 2005)
Volume 32, Issue 5, Pages (May 2010)
Volume 9, Issue 5, Pages (November 1998)
Andrew T Miller, Heather M Wilcox, Zhongbin Lai, Leslie J Berg 
PPARδ Is a Type 1 IFN Target Gene and Inhibits Apoptosis in T Cells
Volume 15, Issue 3, Pages (September 2001)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 35, Issue 2, Pages (August 2011)
Volume 36, Issue 3, Pages (March 2012)
Volume 33, Issue 5, Pages (November 2010)
LAT Links the Pre-BCR to Calcium Signaling
Volume 32, Issue 5, Pages (May 2010)
Volume 27, Issue 2, Pages (August 2007)
Targeted Cleavage of Signaling Proteins by Caspase 3 Inhibits T Cell Receptor Signaling in Anergic T Cells  Irene Puga, Anjana Rao, Fernando Macian  Immunity 
Volume 30, Issue 4, Pages (April 2009)
Volume 33, Issue 1, Pages (July 2010)
Volume 35, Issue 4, Pages (October 2011)
Volume 27, Issue 4, Pages (October 2007)
The CD28 Signaling Pathway Regulates Glucose Metabolism
Volume 31, Issue 6, Pages (December 2009)
Volume 29, Issue 1, Pages (July 2008)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 1, Issue 2, Pages (April 2007)
Volume 26, Issue 3, Pages (March 2007)
RORγt, a Novel Isoform of an Orphan Receptor, Negatively Regulates Fas Ligand Expression and IL-2 Production in T Cells  You-Wen He, Michael L Deftos,
Volume 23, Issue 2, Pages (August 2005)
The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
Presentation transcript:

Volume 24, Issue 6, Pages 703-716 (June 2006) The Noxa/Mcl-1 Axis Regulates Susceptibility to Apoptosis under Glucose Limitation in Dividing T Cells  Nuno L. Alves, Ingrid A.M. Derks, Erik Berk, René Spijker, René A.W. van Lier, Eric Eldering  Immunity  Volume 24, Issue 6, Pages 703-716 (June 2006) DOI: 10.1016/j.immuni.2006.03.018 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 Bcl-2 Family Gene Expression of Naive T Cells after Combined TCR and CD28 Costimulation Naive CD8+ (top) or CD4+ (bottom) T cells were left unstimulated (triangles) or stimulated by either anti-CD3 Ab (squares) or the combination of anti-CD3 Ab + anti-CD28 Ab (diamonds) for 24, 72, and 120 hr. At the designated time points, cells were harvested, total RNA was immediately isolated, and RT-MLPA was performed. Averaged expression profile for three different time points is depicted. The fold induction (mean ± SD from three experiments) for each gene was quantified as expressed in comparison to the value obtained from unstimulated cells (t = 24 hr). Immunity 2006 24, 703-716DOI: (10.1016/j.immuni.2006.03.018) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 2 Specific Induction of Noxa at mRNA and Protein Level after TCR Signaling Is Prevented by PKC Inhibitors (A) Naive CD8+ T cells were analyzed immediately after isolation (naive), left unstimulated (medium), or stimulated with the indicated Abs. Top: total RNA was obtained and subjected to RT-PCR confirming Noxa induction after CD3 and CD3/CD28 triggering for 3 days. Bottom: in the same samples, Noxa protein expression was analyzed by Western blot. Data are representative of three experiments performed. (B) Noxa mRNA expression was analyzed in unstimulated cells, in cells stimulated with anti-CD3 Ab for 3 days (CD3 (d3), in cells subsequently washed and cultured for an additional 2 days (CD3 (d3)+ rest (d2)), and in cells restimulated for 1 day with anti-CD3 Ab (restim.CD3(d1). (C) Naive CD8+ T cells were stimulated with the plate bound anti-CD3 Ab for 24 hr in the presence of different signaling transduction inhibitors. Total RNA was obtained and subjected to RT-PCR analysis for Noxa transcript. Different intracellular signaling pathway inhibitors were tested (from left to right): no treatment, PI3 kinase inhibitor (10 μM), MAP kinase inhibitor (10 μM), p38 inhibitor (10 μM), NFκB inhibitor (Rathmell et al., 2002), staurosporine (10 nM), and cyclosporine (500 ng/ml). (D) PKC-dependent induction of Noxa. Naive CD8+ T cells were left unstimulated or stimulated with the plate bound anti-CD3 Ab for 24 hr in the presence of different PKC inhibitors (from left to right): no treatment, CD3-stimulated, CD3-stimulated + staurosporine (10 nM), CD3-stimulated + BIM (0.2 μM), CD3-stimulated + rottlerin (10 μM). In parallel, cells were stimulated with PMA (1 ng/ml), ionomycin (1 mg/ml), or combined PMA and ionomycin for 4 hr. Data are representative of three experiments performed. Immunity 2006 24, 703-716DOI: (10.1016/j.immuni.2006.03.018) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 3 Noxa Induction in Human Lymphocytes Is p53 Independent (A) CD8+ T cells expressing control-GFP (gray bars) or CD8+ T cells expressing p53i construct (black bars) were left unstimulated, stimulated with anti-CD3 Ab (1 μg/ml) for 24 hr, or γ-irradiated. At the designated time point, cell viability was analyzed by FACS (annexin V/PI staining). (B) Noxa (top) and Puma (bottom) mRNA expression was analyzed by RT-MLPA. (C) Noxa expression was analyzed by Western blot in control or p53i CD8+ T cells. Data are representative of two experiments performed. Immunity 2006 24, 703-716DOI: (10.1016/j.immuni.2006.03.018) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 4 Noxa Is Expressed in Human Dividing T Lymphocytes (A) Induction of Noxa in naive T cells after stimulation with γc cytokines. Naive CD4+ or CD8+ T cells were left unstimulated or stimulated with IL-7 and IL-15 for 24 hr. Noxa and Bcl-2 mRNA expression was analyzed by RT-MLPA. (B) Noxa is highly expressed in dividing Jurkat cells. mRNA was isolated from Jurkat and CD8+ T cells stimulated via CD3/CD28 for 5 days (see also Figure 1). Apoptotic gene expression profile analyzed by RT-MLPA. Top, BH3-only members; bottom, protective members and Bax-like members; survivin is represented as indication of the cell cycle status of cells. Immunity 2006 24, 703-716DOI: (10.1016/j.immuni.2006.03.018) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 5 Involvement of Noxa in Apoptosis Provoked by Glucose Limitation in T Lymphocytes (A) (i) Noxa knockdown was obtained with two different Noxa siRNA constructs. Jurkat T cell line was transduced with pRetro-control GFP (M), pRetro-GFPsiNoxa6 (N6), pRetro-GFPsiNoxa7 (N7), and pRetro-GFPsiNoxa8 (N8). J16 (untransduced cells). (ii) Improved knockdown was achieved by performing a limiting dilution from the bulk N8 population. Total cell lysates derived from GFP+ cells were separated by SDS-PAGE, and Noxa protein levels were monitored by immunoblotting. Actin serves as a loading control. (B) Reduction in Noxa levels confers a competitive advantage under glucose limitation. Untransduced J16 cells (GFP−) were mixed initially at 1:1 ratio with either M, N7, or N8 J16 GFP+ cells and cultured more than 1 week in medium supplemented with 25 mM or 5 mM glucose. At the designated time points, populations were analyzed by FACS first in the live gate and second based on GFP expression. Note that this way of analysis was required since apoptotic cells leak GFP protein. Shown are representative experiments when J16 were mixed with either N8 cells (25 mM glucose, left; and 5 mM glucose, middle) or N8.25 cells (5 mM glucose, right). (C) Survival of Noxa high (J16-GFP−) and Noxa low (N7/8-GFP+) cells during growth. Cell viability was measured based on the percentage of GFP− or GFP+ cells found within the total viable population: top left and middle panel, J16 (circles) and N7 (squares) cells; lower left and middle panel, J16 (circles) and N8 (diamonds) cells. Dashed lines with open symbols represent correspondent populations in cultures supplemented with extra 5 mM glucose on day 2. Top right, J16 (circles) and N8.15 (triangles); lower right, J16 (circles) and N8.25 (diamonds). (D) The ratio between transduced (GFP+) and untransduced (GFP−) cells was calculated in the live gating. Left and middle, M (M:J16) (circles), N7 (N7:J16) (squares), and N8 (N8:J16) (diamonds). Dashed lines with open symbols represent correspondent ratios in cultures supplemented with extra 5 mM glucose on day 2. Right, untransduced (GFP−) cells were mixed with either parental N8 (N8p) (open diamonds), N8.8 (squares), N8.11 (circles), N8.15 (triangles), or N8.25 (filled diamonds). Note that the y axis increases in scale in left, middle, and right, respectively. Data represent mean ± SD from three experiments. Immunity 2006 24, 703-716DOI: (10.1016/j.immuni.2006.03.018) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 6 Role for Noxa in Primary, Activated T Cells under Glucose Limitation (A) Primary T cells were retrovirally transduced with control GFP or N8 constructs, and after sorting to homogeneity, resting or 24 hr CD3/CD28-stimulated cells were tested for Noxa expression. A reduction in Noxa expression was clearly observed in the N8 cells. (B) Top: after transduction and sorting in GFP+Mock (M) and GFP+N8 (N8) populations, primary T cells were treated for 24 hr with 25 μM CCCP to uncouple mitochondrial respiration and thereby trigger apoptosis or with γ-radiation (5 Gy). Competitive assay (middle and bottom): GFP+ N8 cells (N8) were mixed in a 1:1 ration with sorted GFP− cells that underwent the same treatment (C), in complete medium containing 10% or 0% FCS. After restimulation via the CD3+CD28, cells were analyzed for viability at day 0 and day 2. Bottom: cells from two donors were mixed in a 1:1 ratio and triggered via CD3 and CD28 in medium containing low glucose (1 mM) and compared for viability at day 0 and day 2. Cells were scored for viablity: at top presented as % viable cells in the separate cultures; in the middle and bottom panels is presented the % of Noxa high (GFP−) or low (GFP+) cells within the viable gate in the mixed cultures. Numbers indicate the ratios between N8 and C cells in two separate experiments. Immunity 2006 24, 703-716DOI: (10.1016/j.immuni.2006.03.018) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 7 Role of Noxa in T Cell Apoptosis Becomes Apparent when Mcl-1 Levels Decrease (A) In healthy Jurkat cells, Noxa is bound to Mcl-1. Protein lysates were subjected to immunoprecipitation (IP) reactions by anti-Mcl1 or control Ab to evaluate the association of Noxa with Mcl-1 (left). Middle: 5% lysates after IP; right: 5% of total protein lysates, analyzed by Western blotting. The membrane was rehybridized with anti-Bim and anti-β-actin as positive and negative control for the IP, respectively. (B) Noxa and Mcl-1 are present in the mitochondria-rich fraction. Viable Jurkat cells were separated into heavy membrane-enriched (HM), light membrane (LM), and cytosol (C) fractions and probed for the indicated proteins. (C) During glucose-limited conditions, Mcl-1 is degraded, which is prevented if glucose was resupplemented. Mock, N7, N8, transduced Jurkat cells were cultured in medium supplemented with 25 or 5 mM glucose (± extra 5 mM on day 2), for 1 week or 4 days, respectively (25 mM top, 5 mM bottom). At designated time points, Noxa and Mcl-1 protein levels were analyzed by Western blotting. Numbers below the lanes indicate the percentage of viable cells simultaneously determined by FACS analysis. (D) Reduction in Mcl-1 levels renders cells susceptible to apoptosis in glucose-limited conditions. (i) Mcl-1 knockdown was obtained by two different Mcl-1 siRNA constructs. Jurkat T cell line was transduced with pRetro-control GFP (M), pRetro-GFPsiMCL-1.1 (Mcl1i1), and pRetro-GFPsiMcl-1.3 (Mcl1i3). J16 (untransduced cells). (ii) Survival of Mcl-1 low (Mcl-1i1-GFP+) and Mcl-1 high (J16-GFP−) cells during growth. Cell viability was measured as described in Figure 5: J16 (circles) and Mcl-1i1 (diamonds) cells. (iii) In similar experiments as described in Figure 5, the ratio between transduced (GFP+) and untransduced (GFP−) cells was calculated in the live gating, M (M:J16) (circles), Mcl1i1 (Mcl1i1:J16) (diamonds), and Mcl1i3 (Mcl1i3:J16) (triangles). Data represent mean ± SD from three experiments. Immunity 2006 24, 703-716DOI: (10.1016/j.immuni.2006.03.018) Copyright © 2006 Elsevier Inc. Terms and Conditions